AGENDA FOR 2020 MEDINVEST INFECTIOUS DISEASE CONFERENCE
(2021 AGENDA TO BE RELEASED MARCH 20, 2021)
MONDAY, JUNE 15, 2020
All times are in Eastern Time Zone - USA
8:30am // OPENING REMARKS
8:40am // SPEAKER - DR. LYNDA CHIN (Founder, Department of Genomic Medicine at MD Anderson Cancer Center; Co-Founder & CEO, Apricity Health) Topic: Connecting COVID-19 Screening at Workplace with Care and Clinical Trials
9:10am // KEYNOTE TALK - DR. JEROME KIM (Director General of the International Vaccine Institute)
Topic: Developing a Vaccine for COVID-19
09:40am // Corporate Presentation - 4D Pharma
10:00am // Corporate Presentation - Mobidiag
10:20am // Corporate Presentation - Aptorum Group
10:40am // Corporate Presentation - NovaBiotics
11:00am // Corporate Presentation - Moleculera Labs
11:20am // Corporate Presentation - pHion Therapeutics
11:40am // Corporate Presentation - PathoQuest
12:00pm // Corporate Presentation - Primal Therapies
12:20 pm // Corporate Presentation - Mirror Biologics
12:40 pm // Corporate Presentation - RedHill Biopharma
01:00 pm // TALK - BRIAN LELYAND-JONES (Director Darwin Institute, CMO NFCR, Frm Director McGill and Emory Cancer Centers)
Topic: Managing the Inflammatory Effects of COVID-19 and Managing Clinical Trials in the Era of COVID
01:30 pm // Corporate Presentation - SciTech Development
01:50 pm // Corporate Presentation - Chelation Partners
02:10 pm // Corporate Presentation - SIWA Therapeutics
02:30 pm // Corporate Presentation - Tetra BioPharma
02:50 pm // Corporate Presentation - GATTACO
03:10 pm // Corporate Presentation - Airway Therapeutics
03:30 pm // Corporate Presentation - Ashvattha Therapeutics
03:50 pm // Corporate Presentation - DeepSense Biotechnologies
04:10 pm // Corporate Presentation - 20/20 Gene Systems
04:30 pm // Corporate Presentation - Imago Systems
04:50 pm // SPEAKER - DOUGLAS MONTICCIOLO (Founder, CEO, and CIO of Brevet Capital)
Topic: Financing COVID-19 Supplies for Governments and Healthcare Providers While Managing Fraud, Customs, Shipping, and Financial Risk
5:40 pm // CLOSING REMARKS
TUESDAY, JUNE 16, 2020
All times are in Eastern Time Zone - USA
8:30am // OPENING REMARKS
8:40am // KEYNOTE SPEAKER - GEORGE POSTE (Professor, ASU; Former Head of R&D, GSK; Defense Science Board of the U.S. Department of Defense)
Topic: Biosecurity: A Multi-Dimensional Challenge of Escalating Complexity and Urgency
9:10am // SPEAKER - ARTURO CASADEVALL (Chair, Molecular Microbiology & Immunology, Johns Hopkins)
Topic: The Use of Convalescent Serum in COVID-19 Treatment
09:40am // Corporate Presentation - NIBEC
10:00am // Corporate Presentation - Phagelux
10:20am // Corporate Presentation - BactoByte
10:40am // Corporate Presentation - Immuni Therapeutics
11:00am // Corporate Presentation - 7 Hills Pharma
11:20am // Corporate Presentation - Weinberg Medical Physics
11:40am // Corporate Presentation - Microbion Corporation
12:00pm // Corporate Presentation - emocha Health
12:20 pm // Corporate Presentation - Servare Biologics
12:40 pm // Corporate Presentation - Cofactor Genomics
01:00 pm // SPEAKER - DR. ALFRED SLANETZ (CEO Geneius Biotech, Frm CEO Bluebird Bio, Frm Director Product Development Genetech)
Topic: Developing Cellular Therapies for COVID-19
01:30 pm // Corporate Presentation - Geneius Biotechnology
01:50 pm // Corporate Presentation - Decoy Biosystems
02:10 pm // Corporate Presentation - Thrive Bioscience
02:30 pm // Corporate Presentation - Soligenix
02:50 pm // Corporate Presentation - MaxWell Biosciences
03:10 pm // Corporate Presentation - FZata
03:30 pm // Corporate Presentation - Virion Therapeutics
03:50 pm // Corporate Presentation - Adarza Biosystem
04:10 pm // Corporate Presentation - ChipCare Corporation
04:30 pm // Corporate Presentation - OTraces
04:50 pm // Corporate Presentation - Aphios Corporation
05:10 pm // SPEAKER - DR. WENDY ZIAI (Medical Director, Neurovascular Laboratory, Johns Hopkins; Co-Director, Johns Hopkins Bayview Neurocritical Care Unit)
Topic: Managing the Neurological Effects of COVID-19 and Fighting COVID-19 from the Fronts Lines of the ICU
05:40 pm // SPEAKER - DR. ROBERT C. GALLO (Co-Founder and Director, The Institute of Human Virology (IHV) and Co-Founder HIV Virus)
Topic: Re-purposing Polio Vaccine in the War Against COVID-19
06:10 pm // SPEAKER - DR. WOLFGANG KLIETMAN (Harvard Medical School)
Topic: Vaccines and Biodefense
06:40 pm // CLOSING REMARKS